(S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (JJ novel) (NN cancer) (JJ diagnostic) (NN method)) (VP (VBN based) (PP (IN on) (NP (NP (JJ plasma) (NN denaturation) (NNS profiles)) (VP (VBN obtained) (PP (IN by) (NP (NP (DT a) (JJ non-conventional) (NN use)) (PP (IN of) (NP (NNP Differential) (NNP Scanning) (NNP Fluorimetry))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (CD 84) (NN glioma) (NNS patients)) (CC and) (NP (CD 63) (JJ healthy) (NNS controls))) (VP (MD can) (VP (VB be) (VP (ADVP (RB automatically)) (JJ classified) (S (VP (VBG using) (NP (NN denaturation) (NNS profiles)) (PP (IN with) (NP (NP (DT the) (NN help)) (PP (IN of) (NP (NN machine) (VBG learning) (NNS algorithms))))))) (PP (IN with) (NP (ADJP (CD 92) (NN %)) (NN accuracy))))))))) (. .))
(S (NP (VBN Proposed) (JJ high) (NN throughput) (WP workflow)) (VP (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (TO to) (NP (NP (DT any) (NN type)) (PP (IN of) (NP (NN cancer)))))))) (CC and) (VP (MD could) (VP (VB become) (NP (NP (DT a) (JJ powerful) (JJ pan-cancer) (JJ diagnostic) (CC and) (VBG monitoring) (NN tool)) (PP (IN from) (NP (DT a) (JJ simple) (NN blood) (NN test))))))) (. .))
